76.97
price up icon1.45%   1.10
after-market 시간 외 거래: 69.98 -6.99 -9.08%
loading
전일 마감가:
$75.87
열려 있는:
$75.89
하루 거래량:
1.82M
Relative Volume:
0.99
시가총액:
$14.68B
수익:
$4.08B
순이익/손실:
$32.48M
주가수익비율:
40.72
EPS:
1.89
순현금흐름:
$16.80M
1주 성능:
-5.59%
1개월 성능:
+15.94%
6개월 성능:
+34.80%
1년 성능:
+41.83%
1일 변동 폭
Value
$75.42
$77.01
1주일 범위
Value
$73.25
$82.02
52주 변동 폭
Value
$50.35
$83.95

인사이트 코퍼레이션 Stock (INCY) Company Profile

Name
명칭
Incyte Corp
Name
전화
(302) 498-6700
Name
주소
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE
Name
직원
2,524
Name
트위터
@Incyte
Name
다음 수익 날짜
2024-10-29
Name
최신 SEC 제출 서류
Name
INCY's Discussions on Twitter

INCY을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
INCY 76.97 14.68B 4.08B 32.48M 16.80M 1.89
VRTX 467.01 119.87B 10.63B -479.80M -1.35B 13.33
REGN 762.00 83.27B 13.85B 4.65B 3.32B 35.06
ARGX 567.90 33.96B 1.86B -40.29M -1.28B -4.16
ALNY 232.27 30.18B 2.09B -332.26M 16.06M -4.14
BNTX 101.87 24.42B 3.30B -501.07M 1.03B 11.54

인사이트 코퍼레이션 Stock (INCY) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-02-14 다운그레이드 JMP Securities Mkt Outperform → Mkt Perform
2023-12-13 업그레이드 Leerink Partners Market Perform → Outperform
2023-12-04 업그레이드 Guggenheim Neutral → Buy
2023-11-21 다운그레이드 Goldman Buy → Neutral
2023-07-25 개시 Citigroup Buy
2023-05-04 다운그레이드 BofA Securities Buy → Neutral
2023-04-10 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-03-24 업그레이드 SVB Securities Underperform → Market Perform
2023-01-31 개시 Piper Sandler Overweight
2022-08-03 다운그레이드 Evercore ISI Outperform → In-line
2022-08-03 다운그레이드 Guggenheim Buy → Neutral
2022-07-28 개시 Wells Fargo Equal Weight
2022-02-09 다운그레이드 SVB Leerink Mkt Perform → Underperform
2022-01-18 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2021-11-19 개시 BMO Capital Markets Market Perform
2021-07-20 업그레이드 The Benchmark Company Hold → Buy
2021-02-10 다운그레이드 SVB Leerink Mkt Perform → Underperform
2021-01-07 개시 Truist Buy
2021-01-04 업그레이드 Guggenheim Neutral → Buy
2020-06-16 개시 The Benchmark Company Hold
2020-05-06 다운그레이드 JP Morgan Overweight → Neutral
2020-04-29 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-04-01 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-03-24 재개 William Blair Outperform
2020-03-13 업그레이드 BofA/Merrill Neutral → Buy
2020-02-04 재개 BofA/Merrill Neutral
2020-01-03 재확인 BMO Capital Markets Market Perform
2020-01-03 다운그레이드 Mizuho Buy → Neutral
2020-01-02 다운그레이드 Guggenheim Buy → Neutral
2019-10-03 개시 Mizuho Buy
2019-09-12 개시 BMO Capital Markets Market Perform
2019-09-05 업그레이드 JMP Securities Mkt Perform → Mkt Outperform
2019-09-05 재개 Morgan Stanley Equal-Weight
2019-09-05 업그레이드 Oppenheimer Perform → Outperform
2019-05-21 개시 Credit Suisse Neutral
2019-05-03 다운그레이드 Barclays Overweight → Equal Weight
2019-04-11 개시 Stifel Hold
2019-04-03 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2019-01-24 업그레이드 William Blair Mkt Perform → Outperform
모두보기

인사이트 코퍼레이션 주식(INCY)의 최신 뉴스

pulisher
Nov 17, 2024

Seizert Capital Partners LLC Has $6.24 Million Position in Incyte Co. (NASDAQ:INCY) - MarketBeat

Nov 17, 2024
pulisher
Nov 17, 2024

Sumitomo Mitsui Trust Group Inc. Sells 49,495 Shares of Incyte Co. (NASDAQ:INCY) - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Here’s How Jakafi’s Patent Expiry Impacts Incyte Corporation’s (INCY) Growth Prospects - Insider Monkey

Nov 16, 2024
pulisher
Nov 16, 2024

Incyte Co. (NASDAQ:INCY) Shares Purchased by Mizuho Securities USA LLC - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Incyte Co. (NASDAQ:INCY) Shares Sold by Principal Financial Group Inc. - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Incyte Corp. stock outperforms competitors despite losses on the day - MarketWatch

Nov 15, 2024
pulisher
Nov 14, 2024

KBC Group NV Reduces Position in Incyte Co. (NASDAQ:INCY) - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Incyte's SWOT analysis: stock faces patent cliff as pipeline progresses By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 14, 2024

Incyte to Present at Upcoming Investor Conference - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

INCY (Incyte) Cash Flow from Operations : $102 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Incyte's SWOT analysis: stock faces patent cliff as pipeline progresses - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Anal Cancer Market Revenue to Expand Significantly by 2034, States DelveInsight Report | Incyte Corp, BioMimetix, Inovio Pharma, Merck Sharp & Dohme, Dustin Deming, Advaxis - The Globe and Mail

Nov 13, 2024
pulisher
Nov 13, 2024

Anal Cancer Market Revenue to Expand Significantly by 2034, - openPR

Nov 13, 2024
pulisher
Nov 13, 2024

State of New Jersey Common Pension Fund D Reduces Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Incyte Co. (NASDAQ:INCY) Shares Sold by Amalgamated Bank - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Los Angeles Capital Management LLC Lowers Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

Chronic Hand Eczema Pipeline Update 2024: FDA Approvals, - openPR

Nov 11, 2024
pulisher
Nov 09, 2024

Applied Finance Capital Management LLC Reduces Stock Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

Incyte Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Nov 08, 2024
pulisher
Nov 08, 2024

Barry P. Flannelly Sells 3,680 Shares of Incyte Co. (NASDAQ:INCY) Stock - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Incyte Insider Sold Shares Worth $293,210, According to a Recent SEC Filing - Marketscreener.com

Nov 08, 2024
pulisher
Nov 08, 2024

Incyte Co. (NASDAQ:INCY) Stock Holdings Lowered by ARK Investment Management LLC - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Incyte Corp. stock outperforms competitors on strong trading day - MarketWatch

Nov 07, 2024
pulisher
Nov 07, 2024

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Nov 07, 2024
pulisher
Nov 07, 2024

Van ECK Associates Corp Has $8.79 Million Holdings in Incyte Co. (NASDAQ:INCY) - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

Greenwood Capital Associates LLC Acquires Shares of 6,546 Incyte Co. (NASDAQ:INCY) - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Incyte Corporation: Will Their Focus on Oncological Innovations Pay Off?Major Drivers - Smartkarma

Nov 06, 2024
pulisher
Nov 05, 2024

Incyte stock soars to 52-week high, hits $76.58 - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Robeco Institutional Asset Management B.V. Buys 70,596 Shares of Incyte Co. (NASDAQ:INCY) - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

NJ Judge Blocks Sun Pharma From Launching Hair Loss Drug - Law360

Nov 04, 2024
pulisher
Nov 04, 2024

Incyte (NASDAQ:INCY) Sets New 52-Week HighWhat's Next? - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Incyte Corp (INCY)'s Winning Formula: Financial Metrics and Comp - GuruFocus.com

Nov 04, 2024
pulisher
Nov 02, 2024

Incyte Co. (NASDAQ:INCY) Stock Holdings Trimmed by State of Alaska Department of Revenue - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Incyte (NASDAQ:INCY) Posts Quarterly Earnings Results, Misses Expectations By $0.12 EPS - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

INCY Q3 Earnings Miss Estimates, Revenues Beat on Higher Product Sales - MSN

Nov 01, 2024
pulisher
Oct 31, 2024

Incyte Corporation (NASDAQ:INCY) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 31, 2024
pulisher
Oct 31, 2024

14,631 Shares in Incyte Co. (NASDAQ:INCY) Acquired by Integrated Advisors Network LLC - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Incyte Corp (INCY) Q3 2024 Earnings Call Highlights: Strong Reve - GuruFocus.com

Oct 31, 2024
pulisher
Oct 30, 2024

Earnings call: Incyte reports robust growth and pipeline progress - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Incyte's Jakafi Demand Is Strong, Analyst Upgrades Stock - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Incyte Raises Jakafi Sales Forecast, Surpassing Expectations - Finimize

Oct 30, 2024
pulisher
Oct 30, 2024

Incyte (NASDAQ:INCY) Price Target Raised to $71.00 - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Incyte shares target upgraded, outperform rating on strong Q3 sales - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Incyte stock target raised, underperform rating held on Jakafi revenue outlook - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Incyte shares target raised, rating held on strong 3Q results - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Incyte to Present at Upcoming Investor Conferences - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Incyte Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Incyte stock sees upside with strong Jakafi performance and robust pipeline—Citi - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Incyte (INCY) PT Raised to $87 at Leerink Partners - StreetInsider.com

Oct 30, 2024
pulisher
Oct 30, 2024

Incyte (INCY) PT Raised to $97 at Citi - StreetInsider.com

Oct 30, 2024

인사이트 코퍼레이션 (INCY) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$39.51
price up icon 7.22%
$18.98
price up icon 3.66%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
자본화:     |  볼륨(24시간):